Adult Endocrinology and Metabolism — Core of Discipline

C5 Managing diabetes with insulin therapy and the use of diabetes technologies

Key Features:
- This EPA focuses on prescribing insulin therapy for individuals with type 1 and type 2 diabetes, gestational diabetes, and other forms of diabetes.
- This includes ensuring that the individual has appropriate follow-up to assist with titration of insulin and providing appropriate monitoring for side effects (e.g., hypoglycemia and DKA).
- It also includes demonstrating expertise in transitioning patients from basal-bolus insulin to a continuous subcutaneous insulin infusion system/insulin pump therapy.
- It also includes interpretation of continuous glucose monitoring (CGM).

Assessment Plan:
Direct and/or indirect observation by supervisor or diabetes or pump educator
Use Form 1. Form collects information on:
- Type of diabetes: congenital; cystic fibrosis-related; diabetes in pregnancy; monogenic; post-pancreatic surgery; secondary diabetes; type 1; type 2
- Treatment: CGM; multiple daily injections; insulin pump; transition to pump
Collect 10 observations of achievement
- At least 2 diabetes in pregnancy
- At least 1 individual with congenital, cystic fibrosis-related, monogenic, post-pancreatic surgery or secondary diabetes
- At least 3 continuous glucose monitoring
- At least 3 multiple daily injections
- At least 3 insulin pumps
- At least 1 transition to pump
- At least 2 different observers

Form

F1: Observation

Milestones

Context Variables

Requirements